Why are we seeing so much more euglycemic DKA after the introduction of SGLT2 inhibitors? In this video I will go over why so many more Type 2 diabetic patients…
Expert cardiologists discuss the value-based cost benefit and the role for SGLT2 inhibitors in the prevention of HF in patients with and without diabetes. Department of Medicine Grand Rounds UC…
Welcome to Kim E. The Diabetes NP, the ONE STOP SHOP for Nurse Practitioners looking to improve their Diabetes Management & Education Skills! In this video, I discuss one of…
Discussion on the uses and effects of Dipeptyl Peptidase-IV Inhibitors in diabetic patients. For more information log on to our website: http://medwhitecoat.com/ Business email: medwhitecoat@gmail.com Video Rating: / 5
Explore our entire animation video library at: https://www.nonstopneuron.com/ All videos from endocrine pharmacology: https://www.nonstopneuron.com/post/pharmacology-endocrine-system Video Summary: Mechanism of action of SGLT2 inhibitors: They decrease the reabsorption of glucose at the…